Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors [NA]

View source ↗

Summary

Feasibility and expansion trial of transcutaneous vagus nerve stimulation to address immune-related fatigue in patients treated with immune checkpoint inhibitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Vermont Medical Center | Conditions: Cancer-related Fatigue | NA | Status: NOT_YET_RECRUITING